We compared the inoculum effects for 109 recent clinical isolates of the Bacteroidesfragilis group of cefoxitin, cefotetan, ceftizoxime, ceftriaxone, and three (3-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) and their penicillin-derived components. Bactericidal activity was assayed and morphologic changes were monitored for selected strains exhibiting a large inoculum effect. Ceftizoxime demonstrated the largest inoculum effect, followed by cefotetan and ceftriaxone. The large inoculum effect of ceftizoxime and ceftriaxone was correlated with filamentous transformation at the high inoculum (108 CFU/ml) and lack of bactericidal activity suggesting drug destruction or inactivation. Cefotetan was bactericidal for B. fragilis isolates but not for other members of the B. fragilis group. Cefoxitin showed the least inoculum effect and was consistently bactericidal at high (108 CFU/ml), standard (106 CFU/ml), and low (104 CFU/ml) inocula, followed by ampicillin-sulbactam. Piperacillin-tazobactam and ticarcillin-clavulanic acid showed an intermediate inoculum effect. The degree of inoculum effect observed generally correlated with bactericidal activity at all inocula.
The inoculum effect, a large increase in the MIC occurring with an increase in the inoculum size of a microorganism, is one of the variables that influence susceptibility testing and occurs primarily with beta-lactam antibiotics (7, 8, 11, 16) . A number of studies have shown that the Bacteroides fragilis group species produce 1-lactamases and may exhibit an inoculum effect (3, 5, 7, 16, 23, 24) . Sutter et al. (21) have suggested that both large and small inocula should be used to detect resistance of anaerobic bacteria to beta-lactam agents. In a recent review on the inoculum effect, Brook (7) summarized the laboratory experience to date with B. fragilis group species and noted that while some of the cephalosporins had been studied, there was scant data on the P-lactamase inhibitor combinations and their penicillin-derived components (1, 3, 17, 18) . It seems important to evaluate the 1-lactamase inhibitor combinations since these compounds are used in clinical situations where B. fragilis group species are 'potential pathogens and an increased density' of inoculum might cause increased enzymatic destruction.
Consequently, we have compared the inoculum effect for clinical isolate-s of B. fragilis group species and the bactericidal activity of cefoxitin, ceftizoxime, ceftriaxone, and three P-lactamase inhibitors and their penicillin-derived components.
MATERIALS AND METHODS
Organisms. A total of 109 recent, sequentially collected clinical isolates of the B. fragilis group were studied (B. fragilis, 26 strains; B. thetaiotaomicron, 23 strains; B. ova-INOCULUM EFFECT FOR B. FRAGILIS GROUP 1869 inoculum was prepared by suspending a sufficient number of colonies in Anaerobe Broth MIC to achieve a visual turbidity equal to McFarland standard no. 1. This was diluted 1:100 to achieve the 106-CFU/ml inoculum. The 106-CFU/ml inoculum was diluted 1:100 to prepare the 104-CFU/ml inoculum. Inoculum densities were verified by quantitative plating onto BBA for several strains each day of the test. The microdilution plates were thawed and conditioned in the anaerobic chamber (Anaerobe Systems) for 4 h prior to inoculation. Fifty microliters of the inoculum was added to each well containing 50 microliters of the diluted antibiotics. Growth controls containing no antibiotic and broth controls containing no organism were included in each run. Additionally, an inoculum control containing 1 drop of 10% formalin was included because 108 CFU/ml produces a small button in the wells. Trays were inoculated with an automatic pipet (Rainin Instruments Co. Inc., Woburn, Mass.), sealed, and incubated for 48 h. All manipulations were carried out within an anaerobic chamber. For the trays containing 106-and 104-CFU/ml inocula, the MIC was defined as the lowest concentration of antibiotic that caused complete inhibition of growth. For trays containing the 108-CFU/ml inoculum, inhibition of growth was defined as wells that showed no growth or a button less than twice the diameter of the inoculum control.
Kill curves. Selected strains that showed a large inoculum effect were selected for further study. B. fragilis ATCC 25285 was chosen as a control. Prereduced anaerobically sterilized Anaerobe Broth MIC with resazurin Eh indicator (1 mg/liter) was prepared by combining ingredients in the anaerobic chamber. The broth was boiled until the resazurin became colorless, and then 45 ml was dispensed into 100-ml serum vials. The vials were capped with butyl rubber septa and aluminum seals, and the seals were crimped to create an airtight cap. The vials were then removed from the anaerobic chamber and sterilized at 250°C for 15 min. All broths were colorless prior to use. Antibiotics were added at the following concentrations (in micrograms per milliliter): ampicillin, 16; ampicillin-sulbactam, 16/8; ticarcillin, 64; ticarcillin-clavulanic acid, 64/2; piperacillin, 64; piperacillin-tazobactam, 64/8; and cefoxitin, cefotetan, ceftizoxime, and ceftriaxone, 32.
Inocula were prepared by incubating the test strain overnight in a vial containing the prereduced anaerobically sterilized Anaerobe Broth MIC on a shaker at 36°C. Depending on the turbidity, the overnight culture was diluted 1:2 to 1:5 and 5 ml was added to the prewarmed test vials for a 108-CFU/ml inoculum. A 1:100 dilution was prepared, and 5 ml was added to the test vials to obtain the 106-CFU/ml inoculum. Antibiotics and inoculum were added to the anaerobic chamber by using plastic syringes that had been preconditioned in the anaerobic chamber for at least 24 h prior to use to avoid oxidizing the cultures. Incubation was on a shaker in an aerobic incubator. The resazurin remained colorless throughout the incubation. Growth was quantified at the time of inoculation and at 3, 6, 9, and 24 h by removing aliquots from the vials by using a syringe equipped with a 25-gauge needle. The aliquots were transferred into the anaerobic chamber, 10-fold dilutions were prepared, and 0.1 ml of the appropriate dilutions was plated onto BBA by means of a Rotaplate (Fisher Scientific, Indiana, Pa.). The plates were incubated for 48 to 72 h, and colonies were counted. Wet mounts from the 108-CFU/ml bottles were examined for morphologic changes at 3 and 6 h. fragilis group were >128 jig/ml at both the 106-and 108-CFU/ml inocula. Overall, MIC90s, geometric mean MICs, and the inoculum effect were higher with ceftizoxime and ceftriaxone and the parent penicillin compounds (ampicillin, piperacillin, ticarcillin) than with cefoxitin, cefotetan, and the P-lactamase inhibitor combinations.
RESULTS
Killing kinetics. Against B. fragilis ATCC 25289 ( Fig. 1 ), ceftizoxime showed bacteriostatic activity and ampicillin and ceftriaxone showed regrowth at 24 h with the 108-CFU/ml inoculum. Examination of the broth cultures containing ceftizoxime and ceftriaxone showed gross turbidity at the 108-CFU/ml inoculum and tangled, elongated forms on wet mount ( Table 2 ). The other agents tested were bactericidal at 24 h at all inocula. Our clinical strain, B. fragilis 4147 (data not shown) showed killing kinetics similar to those of B. fragilis ATCC 25289.
B. fragilis 4347 (Fig. 2) , a strain exhibiting a large inoculum effect, was not killed by ampicillin, ticarcillin, or piperacillin, but ampicillin-sulbactam, piperacillin-tazobactam, and ticarcillin-clavulanic acid were bactericidal. Results for the cephalosporins tested are not shown in Fig. 2 since the organism was resistant to them even at the low inoculum.
B. thetaiotaomicron 3118 (Fig. 3) shows a pattern similar to that of B. fragilis 4347 with no or poor bactericidal activity by ampicillin, piperacillin, and ticarcillin but good bactericidal activity at both inocula by these agents when combined with their ,B-lactamase inhibitors. Elongated forms were present at the 108-CFU/ml inoculum on the wet mounts of ampicillin, ticarcillin, and piperacillin. Again, the data for the cephalosporins are not shown as the isolate was resistant to them even at the low inoculum.
B. ovatus 3119 (Fig. 4) was susceptible to all the 1-lactamase inhibitor combinations, and therefore they are not shown in Fig. 4 106-CFU/ml inoculum but bacteriostatic with regrowth occurring at 24 h for the 108-CFU/ml inoculum.
B. distasonis 3568 (Fig. 5) showed bactericidal activity at both inocula for the ,-lactamase inhibitor combinations but not for their penicillin-derived components. B. vulgatus 2269 (Fig. 6) showed bactericidal activity at both inocula only for piperacillin-tazobactam. Ticarcillin-clavulanic acid was somewhat active at the low inoculum, and ampicillin-sulbactam showed little activity. MICs of ceftizoxime, ceftriaxone, and cefotetan, but not cefoxitin, were above the breakpoint at the 106-CFU/ml inoculum for these two organisms, and therefore these data are not displayed.
Morphological changes. Table 2 describes the morphological changes with a 108-CFU/ml inoculum after exposure to various antimicrobial agents for 3 to 6 h of incubation. The penicillins, ceftizoxime, and ceftriaxone showed elongated forms. B. distasonis showed elongated forms with exposure to piperacillin and piperacillin-tazobactam which were still bactericidal. Elongated forms were not noted with the other 3-lactamase inhibitor combinations. Spheroplast formation was most notable for cefoxitin and the 1-lactamase inhibitor combinations.
DISCUSSION
In a review of the inoculum effect, Brook (7) . noted that there was little inoculum effect observed for the B. fragilis group with cefoxitin but that most of the other beta-lactams tested, especially ceftizoxime, exhibited a marked inoculum effect. In our study, ceftizoxime exhibited the largest and cefoxitin the least inoculum effect. Inoculum concentration showed little or no influence on kill kinetics of cefoxitin.
The studies noted by Brook (7) either tested all the combined B. fragilis group species without identification by species or listed only the species B. fragilis as tested. The studies cited also used a variety of methods and; inocula. Our data indicate that variation in inoculum effect is-also species dependent. In general, B. fragilis and then B. thetaiotaomicron showed the greatest and B. ovatus and B. vulgatus showed the least inoculum effect. With piperacillin-tazobactam, B. distasonis showed the greatest inoculum effect, with B. fragilis second. With ceftizoxime and ceftriaxone, the order of inoculum effect was B. fragilis > B. thetaiotaomicron > B. distasonis > B. ovatus = B. vulgatus (Table 1) . Recent in vivo studies (19) note that the inoculum effect may have clinical significance. If this is the case, it would therefore seem important for clinical laboratories to consider identification to species level of the B. fragilis group members in assisting clinicians to help choose therapeutic regimens.
Ceftizoxime and ceftriaxone had a marked inoculum effect that was substantially underestimated by the geometric mean calculations. For the 108-CFU/ml inoculum, the geometric mean could be considered incalculable since MICs for >20 to 50% of the strains were !128 jig/ml. For these strains, 256 p,g/ml was taken as the number in the calculations of the geometric mean. However high they may appear, they could be artificially low. Inactivation or drug destruction are possible explanations for the inoculum effect seen with ceftizoxime and ceftriaxone. The hypothesis of drug destruction is supported by the findings of Aldridge et al. (1) . Studying cefoxitin-resistant B. fragilis group isolates, they noted that the addition of sulbactam to ceftizoxime markedly reduced the MICs of ceftizoxime.
Additional concerns exist regarding the susceptibility testing of ceftizoxime against B. fragilis in that marked differences in MICs have been noted when the agar dilution and broth dilution methods have been used (2, 4, 23) . Which Fig.  1 Cefotetan showed activity equivalent to that of cefoxitin against B. fragilis at both inocula, but geometric mean MICs and MIC90s for B. distasonis, B. ovatus, and B. thetaiotaomicron were higher with cefotetan than with cefoxitin. This is in accord with prior studies (10, 13) that note variability in the in vitro activity of cefotetan against individual members of the B. fragilis group species.
Ceftriaxone generally showed poorer in vitro activity against all member species of the B. fragilis group than cefoxitin or ceftizoxime. Additionally, ceftriaxone also exhibited a relatively large inoculum effect. Filamentous transformation was seen at the high inoculum and correlated with bacteriostatic activity.
A A/S T T/C P P/T GC (12) , who used a mouse model with mixed Escherichia coli-B. fragilis subcutaneous infection and noted that amoxicillin-clavulanic acid was better able to "arrest the progression of infection" than was ampicillinsulbactam, "even when a comparatively low inoculum was tested." Our study also showed piperacillin-tazobactam displayed an inoculum effect when tested against B. distasonis and B. thetaiotaomicron. Most strains remained susceptible to the ,-lactamase inhibitor combinations at the 108-CFU/ml inoculum and produced spheroplasts in most instances.
The present study and prior studies (3, 14) note a marked difference in the inoculum effect of some 1-lactamase inhibitor combinations on members of the family Enterobacteriaceae compared with the effect on the B. fragilis group. This disparity may be due to the lack of induction and lower 3-lactamase production of the B. fragilis group species compared with members of the Enterobacteriaceae.
It would seem prudent to evaluate each new organism, single-agent antibiotic, and antibiotic combination, such as the new ,-lactamase inhibitor combinations, with regard to the inoculum effect. This may be important in clinical situations, especially infections with the B. fragilis group species, which form abscesses that often have high inocula and in which inactivation or drug destruction might occur but be undetected by a standard 106-CFU/ml inoculum (22) .
